MFAP5 hFc Chimera, Mouse
MFAP5 HFc Chimera, Mouse

The purity of MFAP5 hFc Chimera, Mouse is greater than 95% as determined by SEC-HPLC.

MFAP5 HFc Chimera, Mouse

MFAP5 hFc Chimera, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

MFAP5 hFc Chimera, Mouse

Human basal-like breast cancer (BLBC) is an aggressive malignancy with poor prognosis. Since most current treatments are ineffective, there is an urgent need to identify therapeutic targets for BLBC. Microfibrillar-associated protein 5 (MFAP5) plays an important role in the integration of elastic microfibers and the regulation of endothelial cell behaviors.MFAP5 was significantly overexpressed in BLBC tissues and associated with poor metastasis-free survival of patients with BLBC.
Z06268
¥63,425.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
MFAP5 (Gln29-Leu164)_x000D_
Accession # Q9QZJ6		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 42.4 kDa
Apparent Molecular Weight Due to furin cleavage and glycosylation, the protein migrates to 32-38 kDa and 50-65 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • MFAP5 HFc Chimera, Mouse
    • MFAP5 HFc Chimera, Mouse

    The purity of MFAP5 hFc Chimera, Mouse is greater than 95% as determined by SEC-HPLC.

  • MFAP5 HFc Chimera, Mouse
    • MFAP5 HFc Chimera, Mouse

    MFAP5 hFc Chimera, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Human basal-like breast cancer (BLBC) is an aggressive malignancy with poor prognosis. Since most current treatments are ineffective, there is an urgent need to identify therapeutic targets for BLBC. Microfibrillar-associated protein 5 (MFAP5) plays an important role in the integration of elastic microfibers and the regulation of endothelial cell behaviors.MFAP5 was significantly overexpressed in BLBC tissues and associated with poor metastasis-free survival of patients with BLBC.
Synonyms MFAP-5; MAGP-2; MAGP2; MP25; AAT9

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.